Literature DB >> 29876803

Oxidative Stress in Spinocerebellar Ataxia Type 7 Is Associated with Disease Severity.

Y Torres-Ramos1, A Montoya-Estrada1, B Cisneros2, K Tercero-Pérez3, G León-Reyes1, N Leyva-García4, Oscar Hernández-Hernández5, Jonathan J Magaña6.   

Abstract

Spinocerebellar ataxia type 7 is a neurodegenerative inherited disease caused by a CAG expansion in the coding region of the ATXN7 gene, which results in the synthesis of polyglutamine-containing ataxin-7. Expression of mutant ataxin-7 disturbs different cell processes, including transcriptional regulation, protein conformation and clearance, autophagy, and glutamate transport; however, mechanisms underlying neurodegeneration in SCA7 are still unknown. Implication of oxidative stress in the pathogenesis of various neurodegenerative diseases, including polyglutamine disorders, has recently emerged. We perform a cross-sectional study to determine for the first time pheripheral levels of different oxidative stress markers in 29 SCA7 patients and 28 age- and sex-matched healthy subjects. Patients with SCA7 exhibit oxidative damage to lipids (high levels of lipid hydroperoxides and malondialdehyde) and proteins (elevated levels of advanced oxidation protein products and protein carbonyls). Furthermore, SCA7 patients showed enhanced activity of various anti-oxidant enzymes (glutathione reductase, glutathione peroxidase, and paraoxonase) as well as increased total anti-oxidant capacity, which suggest that activation of the antioxidant defense system might occur to counteract oxidant damage. Strikingly, we found positive correlation between some altered oxidative stress markers and disease severity, as determined by different clinical scales, with early-onset patients showing a more severe disturbance of the redox system than adult-onset patients. In summay, our results suggest that oxidative stress might contribute to SCA7 pathogenesis. Furthermore, oxidative stress biomarkers that were found relevant to SCA7 in this study could be useful to follow disease progression and monitor therapeutic intervention.

Entities:  

Keywords:  Antioxidant defense; Blood biomarkers; Lipid oxidation; Oxidative stress; Protein oxidation; Spinocerebellar ataxia type 7

Mesh:

Substances:

Year:  2018        PMID: 29876803     DOI: 10.1007/s12311-018-0947-0

Source DB:  PubMed          Journal:  Cerebellum        ISSN: 1473-4222            Impact factor:   3.847


  43 in total

1.  Central role of the proteasome in senescence and survival of human fibroblasts: induction of a senescence-like phenotype upon its inhibition and resistance to stress upon its activation.

Authors:  Niki Chondrogianni; Fiona L L Stratford; Ioannis P Trougakos; Bertrand Friguet; A Jennifer Rivett; Efstathios S Gonos
Journal:  J Biol Chem       Date:  2003-05-07       Impact factor: 5.157

2.  A rapid colorimetric assay for dry weight.

Authors:  A Bernal; J D Méndez; A Rosado
Journal:  Arch Invest Med (Mex)       Date:  1981

3.  Aqueous extract of Gardenia jasminoides targeting oxidative stress to reduce polyQ aggregation in cell models of spinocerebellar ataxia 3.

Authors:  Kuo-Hsuan Chang; Wan-Ling Chen; Yih-Ru Wu; Te-Hsien Lin; Yi-Ci Wu; Chih-Ying Chao; Jung-Yaw Lin; Li-Ching Lee; Yi-Chun Chen; Guey-Jen Lee-Chen; Chiung-Mei Chen
Journal:  Neuropharmacology       Date:  2014-01-31       Impact factor: 5.250

4.  Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.

Authors:  M Aviram; M Rosenblat; C L Bisgaier; R S Newton; S L Primo-Parmo; B N La Du
Journal:  J Clin Invest       Date:  1998-04-15       Impact factor: 14.808

5.  Protein carbonyl groups as biomarkers of oxidative stress.

Authors:  Isabella Dalle-Donne; Ranieri Rossi; Daniela Giustarini; Aldo Milzani; Roberto Colombo
Journal:  Clin Chim Acta       Date:  2003-03       Impact factor: 3.786

6.  Cloning of the SCA7 gene reveals a highly unstable CAG repeat expansion.

Authors:  G David; N Abbas; G Stevanin; A Dürr; G Yvert; G Cancel; C Weber; G Imbert; F Saudou; E Antoniou; H Drabkin; R Gemmill; P Giunti; A Benomar; N Wood; M Ruberg; Y Agid; J L Mandel; A Brice
Journal:  Nat Genet       Date:  1997-09       Impact factor: 38.330

7.  Aggregation of Polyglutamine-expanded Ataxin 7 Protein Specifically Sequesters Ubiquitin-specific Protease 22 and Deteriorates Its Deubiquitinating Function in the Spt-Ada-Gcn5-Acetyltransferase (SAGA) Complex.

Authors:  Hui Yang; Shuai Liu; Wen-Tian He; Jian Zhao; Lei-Lei Jiang; Hong-Yu Hu
Journal:  J Biol Chem       Date:  2015-07-20       Impact factor: 5.157

8.  Spinocerebellar ataxia type 7: a neurodegenerative disorder with peripheral neuropathy.

Authors:  José Salas-Vargas; Jocelyn Mancera-Gervacio; Luis Velázquez-Pérez; Roberto Rodrígez-Labrada; Emilio Martínez-Cruz; Jonathan J Magaña; Alfredo Durand-Rivera; Oscar Hernández-Hernández; Bulmaro Cisneros; Rigoberto Gonzalez-Piña
Journal:  Eur Neurol       Date:  2015-01-20       Impact factor: 1.710

9.  Proteomic and oxidative stress analysis in human brain samples of Huntington disease.

Authors:  Ma Alba Sorolla; Gemma Reverter-Branchat; Jordi Tamarit; Isidre Ferrer; Joaquim Ros; Elisa Cabiscol
Journal:  Free Radic Biol Med       Date:  2008-05-28       Impact factor: 7.376

10.  Ataxin-3 protects cells against H2O2-induced oxidative stress by enhancing the interaction between Bcl-X(L) and Bax.

Authors:  L Zhou; H Wang; P Wang; H Ren; D Chen; Z Ying; G Wang
Journal:  Neuroscience       Date:  2013-04-02       Impact factor: 3.590

View more
  9 in total

Review 1.  Molecular Targets and Therapeutic Strategies in Spinocerebellar Ataxia Type 7.

Authors:  Anna Niewiadomska-Cimicka; Yvon Trottier
Journal:  Neurotherapeutics       Date:  2019-10       Impact factor: 7.620

Review 2.  Naturally Occurring Antioxidant Therapy in Alzheimer's Disease.

Authors:  Andrila E Collins; Tarek M Saleh; Bettina E Kalisch
Journal:  Antioxidants (Basel)       Date:  2022-01-23

3.  Effects of Physical Rehabilitation in Patients with Spinocerebellar Ataxia Type 7.

Authors:  Karla Tercero-Pérez; Hernán Cortés; Yessica Torres-Ramos; Roberto Rodríguez-Labrada; César M Cerecedo-Zapata; Oscar Hernández-Hernández; Nelson Pérez-González; Rigoberto González-Piña; Norberto Leyva-García; Bulmaro Cisneros; Luis Velázquez-Pérez; Jonathan J Magaña
Journal:  Cerebellum       Date:  2019-06       Impact factor: 3.847

Review 4.  Founder Effects of Spinocerebellar Ataxias in the American Continents and the Caribbean.

Authors:  Roberto Rodríguez-Labrada; Ana Carolina Martins; Jonathan J Magaña; Yaimeé Vazquez-Mojena; Jacqueline Medrano-Montero; Juan Fernandez-Ruíz; Bulmaro Cisneros; Helio Teive; Karen N McFarland; Maria Luiza Saraiva-Pereira; César M Cerecedo-Zapata; Christopher M Gomez; Tetsuo Ashizawa; Luis Velázquez-Pérez; Laura Bannach Jardim
Journal:  Cerebellum       Date:  2020-06       Impact factor: 3.847

5.  Redox Imbalance Associates with Clinical Worsening in Spinocerebellar Ataxia Type 2.

Authors:  Almaguer-Gotay Dennis; Luis E Almaguer-Mederos; Rodríguez-Aguilera Raúl; Rodríguez-Labrada Roberto; Velázquez-Pérez Luis; Cuello-Almarales Dany; González-Zaldívar Yanetza; Vázquez-Mojena Yaimeé; Estupiñán-Domínguez Annelié; Peña-Acosta Arnoy; Torres-Vega Reydenis
Journal:  Oxid Med Cell Longev       Date:  2021-02-19       Impact factor: 6.543

6.  Altered Plasma Acylcarnitines and Amino Acids Profile in Spinocerebellar Ataxia Type 7.

Authors:  Rafael Nambo-Venegas; Claudia Valdez-Vargas; Bulmaro Cisneros; Berenice Palacios-González; Marcela Vela-Amieva; Isabel Ibarra-González; César M Cerecedo-Zapata; Emilio Martínez-Cruz; Hernán Cortés; Juan P Reyes-Grajeda; Jonathan J Magaña
Journal:  Biomolecules       Date:  2020-03-03

Review 7.  Therapeutic roles of natural remedies in combating hereditary ataxia: A systematic review.

Authors:  Michael Weng Lok Phang; Sze Yuen Lew; Ivy Chung; William Kiong-Seng Lim; Lee Wei Lim; Kah Hui Wong
Journal:  Chin Med       Date:  2021-01-28       Impact factor: 5.455

Review 8.  DNA Repair in Huntington's Disease and Spinocerebellar Ataxias: Somatic Instability and Alternative Hypotheses.

Authors:  Tamara Maiuri; Claudia L K Hung; Celeste Suart; Nola Begeja; Carlos Barba-Bazan; Yi Peng; Natasha Savic; Timothy Wong; Ray Truant
Journal:  J Huntingtons Dis       Date:  2021

9.  Accumulation of senescence observed in spinocerebellar ataxia type 7 mouse model.

Authors:  William Miller; Charles Lewis Humphrey Pruett; William Stone; Cindy Eide; Megan Riddle; Courtney Popp; Matthew Yousefzadeh; Christopher Lees; Davis Seelig; Elizabeth Thompson; Harry Orr; Laura Niedernhofer; Jakub Tolar
Journal:  PLoS One       Date:  2022-10-17       Impact factor: 3.752

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.